Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Sell if your investment thesis changes or the company's fundamentals deteriorate. Consider selling when a company is acquired, especially in all-cash deals. Rebalance your portfolio by selling if ...
J.B. Maverick is an active trader, commodity futures broker, and stock market analyst 17+ years of experience, in addition to 10+ years of experience as a finance writer and book editor. Amy is an ACA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results